Federal Policies Must Incentivize Rare Disease Drug Development, Not Hinder It

For most of my daughters’ lives, I lived with the reality that any day could be their last. After they were both diagnosed with cystic fibrosis (CF), our lives centered around constant check-ups, testing, and a revolving door of pills, inhalers, and other medications to manage their symptoms.
Read more